Developing a personalised immunotherapy against melanoma, a type of skin cancer, is the aim of the new spin-off company: Nema Health SL.

Silibinin, a natural molecule from milk thistle, blocks a key protein in cancer metastasis that has so far resisted therapeutic manipulation. A study by the Girona Biomedical Research Institute (IDIBGI) and the Catalan Institute of Oncology (ICO) has identified an inhibitor of a key protein in …

Thanks to Mamapop funding, researchers in Lleida have been able to identify genetic variation schemes in patients with ERBB-2 positive breast cancer, a finding that will improve the treatment of these patients by offering them a more personalised option. The research was recently published …

The project will make possible the classification of the different types of breast cancer and predict the probability of metastasis thanks to the joint analysis of radiological and microscopic images. It will be led by researcher Domènec Puig from the Institut d’Investigació Sanitària Pere Virgili …

Inhibition of the ERK5 protein kinase reduces the proliferation and survival of endometrial cancer cells, and potentiates standard chemotherapy Endometrial cancer is the most common type of gynecological cancer and is the fourth most common type of tumor in women in developed countries. Although it …

IDIBGI and ICO Girona participate in a five-year project, funded with 10 million € and involving 17 partner institutions, led by IRB Barcelona.The aim of the consortium is to implement and systematize the interpretation of tumor sequencing in clinical decision-making so that physicians can select …

Research by IRBLleida and the UdL lays the foundations for possible future combined therapies by identifying a death pathway in tumour cells Glioblastoma is the most common and aggressive brain cancer, due to its ability to evade the immune system and grow. The Calcium …